Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lièvre

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Therapie|March 1, 1995
[Modification of the law of 20/12/88 on the protection of subjects participating in biomedical research]M Lièvre
La Revue Du Praticien|January 25, 2002
[Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials]M Lièvre
Therapie|March 1, 1992
[Evaluation criteria for protocols submitted to the consultant committee for protection of persons in biomedical research (CCPPRB) Lyon-C]M Lièvre
Therapie|January 1, 1997
[Nifedipine and coronary insufficiency: reasons for controversy]M Lièvre, M Cucherat
Therapie|November 1, 1993
[Calcium antagonists in the secondary prevention of myocardial infarction]M Lièvre, P Nony
Diabetes Care|May 20, 1999
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patientsM Lièvre, M Marre
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 1, 1993
[Calcium channel antagonists and myocardial ischemia or ischemia/reperfusion]M Lièvre, J P Boissel
Presse Medicale (Paris, France : 1983)|June 16, 2000
[Clinical benefits of cholesterol lowering treatments. Meta-analysis of randomized therapeutic trials]M Cucherat, M Lièvre, F Gueyffier
International Journal of Cardiac Imaging|February 1, 1997
Validation of a new quantitative coronary angiography analysis system used to evaluate densitometric lumen remodellingM Lièvre, G Finet, J Maupas
Annales Pharmaceutiques Francaises|January 1, 1985
[Cardiovascular effects of hyperoside extracted from hawthorn in anesthetized dogs]M Lièvre, J L Andrieu, A Baconin
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Therapie|March 1, 1995
[Modification of the law of 20/12/88 on the protection of subjects participating in biomedical research]M Lièvre
La Revue Du Praticien|January 25, 2002
[Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials]M Lièvre
Therapie|March 1, 1992
[Evaluation criteria for protocols submitted to the consultant committee for protection of persons in biomedical research (CCPPRB) Lyon-C]M Lièvre
Therapie|January 1, 1997
[Nifedipine and coronary insufficiency: reasons for controversy]M Lièvre, M Cucherat
Therapie|November 1, 1993
[Calcium antagonists in the secondary prevention of myocardial infarction]M Lièvre, P Nony
Diabetes Care|May 20, 1999
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patientsM Lièvre, M Marre
Archives Des Maladies Du Coeur Et Des Vaisseaux|July 1, 1993
[Calcium channel antagonists and myocardial ischemia or ischemia/reperfusion]M Lièvre, J P Boissel
Presse Medicale (Paris, France : 1983)|June 16, 2000
[Clinical benefits of cholesterol lowering treatments. Meta-analysis of randomized therapeutic trials]M Cucherat, M Lièvre, F Gueyffier
International Journal of Cardiac Imaging|February 1, 1997
Validation of a new quantitative coronary angiography analysis system used to evaluate densitometric lumen remodellingM Lièvre, G Finet, J Maupas
Annales Pharmaceutiques Francaises|January 1, 1985
[Cardiovascular effects of hyperoside extracted from hawthorn in anesthetized dogs]M Lièvre, J L Andrieu, A Baconin
Pageof 5